More articles from From the editor
- New cholesterol guidelines: Better, but harder to follow
The new guidelines on lowering cholesterol are good in theory but may prove cumbersome in practice.
- C-reactive protein: It’s back
Who would have thought that CRP, long used in rheumatology, would be a marker of coronary disease?
- The domino effect of the strangulation of post-acute care
Regulatory fixes often have unintended consequences.
- Unproven therapies and media hype
We should be wary of unproven treatments that may he worse than the disease.
- Rare but serious adverse effects in commonly used drugs
Some adverse effects come to light only after millions of people have taken a drug.
- New findings in multiple sclerosis: A message for primary care clinicians
Every once in a while, a new finding transforms the diagnosis and treatment of a disease.
- Addressing both sides of a difficult controversy
Should a promising technology be widely applied before the data are in?
- Fly-fishing and painting inspire CCJM Art Director’s Homeric odyssey
Artist, biographer, and fisherman—Bob Demarest, our Art Director, is a man of many talents.
- The return of The Clinical Picture
Sharpen your powers of observation with our revived question-and-answer quiz.
- What’s your opinion of CCJM’s Patient Information page?
Is our Patient Information page useful “as is,” or are changes in order? Let us know.